Moderna: Pfizer Seeking ‘Two Bites At The Invalidity Apple’ With Patent Challenge
ALEXANDRIA, Va. — A petition by Pfizer Inc. for inter partes review (IPR) of a Moderna TX Inc. patent directed to the messenger RNA technology used in the COVID-19 vaccine is...To view the full article, register now.
Already a subscriber? Click here to view full article